Skip to main content
. 2025 Jul 18;13:74. doi: 10.1186/s40635-025-00781-5

Table 3.

Summary of study questions, measures and conclusions for studies with lung injury targeting or resulting in PaO2/FiO2s ≤ 100mmHg

Author (y) Question Measures* Conclusions†
Studies that compared an MV alone group with an ECMO group
 Plotz (1993) Compared surfactant with positive pressure-controlled ventilation vs. with V-V ECMO with sighs Weaning success, GasEx§, lung mechanics§, ventilator efficiency Large volume surfactant instillation was possible with V-V ECMO and sighs
 German (1996) Compare effects of MV with NO vs with V-V ECMO on Hemos, GasEx and lung lymph drainage during Hemos§, GasEx, lung lymph flow and protein concentration NO reduced PVR and increased oxygenation and lung lymph flow; ECMO improved oxygenation more and removed CO2
 Iglesias (2008) Compare conventional MV with 10-12mL/kg or 6mL/kg vs A-V ECMO with near-static ventilation Weaning success, Hemos, GasEx, lung mechanics, LIS, lung IL-6, IL-8, TNFα, surfactant A-V ECMO and near-static ventilation improved outcomes versus conventional MV
 Araos (2016) Compare the effects of V-V ECMO to MV alone Survival, Hemos, GasEx, lung mechanics, LIS, W/D ECMO rescued an MV refractory lung injury model and will allow testing of other V-V ECMO interventions
 Huang (2022) Investigate if V-V ECMO is protective and if Hippo/YAP signaling contributes to that protection Oxygenation, LIS, W/D, AT2 cells, BAL and lung tissue IL-6, IL-8 and TNFα, Hippo/YAP signaling markers V-V ECMO stimulated Hippo/YAP signaling aided recovery of injured alveolar epithelium
Studies that compared an MV alone group to two different ECMO groups
 Yanos (1990) Investigate whether V-V ECMO supported hypopnea would reduce lung edema Hemos, GasEx, lung mechanics, W/D, lung H2O V-V ECMO supported hypopnea decreased Paw and PAP and increased PaO2 but didn’t alter lung water and increased venous admixture
 Johannes (2014) Compare effects of reducing TV to 3mL/kg or apneic ventilation with A-V ECMO vs. MV with 6mL/kg alone Hemos, GasEx, lung mechanics, regional LIS A-V ECMO allowed TV decreases to 0mL and reduced upper lung hyperinflation but increased lower lung inflammation
 Pilarczyk (2015) Compare conventional V-V ECMO to a miniaturized oxygenator with rotary pump Hemos, GasEx, CBC, LFTs, free Hb, pump characteristics Miniaturized system supported Hemos and GasEx but increased hemolysis
Studies that compared differing ECMO groups
 Hirschl (1995) Investigate if liquid vs gas ventilation improves lung function during support with V-V ECMO Hemos, GasEx, lung mechanics, histology Liquid ventilation improved GasEx, lung compliance, and lung injury and inflammation
 Hirschl (1996) Investigate if total followed by partial liquid ventilation vs. gas ventilation improves lung function supported with V-V ECMO Hemos, GasEx, lung mechanics, histology Total followed by partial liquid ventilation improved GasEx, lung injury and inflammation but only total liquid ventilation improved compliance
 Kopp (2009) Investigate if a low resistance oxygenator without blood pump or an oxygenator with a miniaturized pump improves hemocompatibility vs. conventional V-V ECMO Coagulation studies (ACT, PTT, PT, TAT, Fibrinogen, PLTs), thromboelastography, CBC, serum IL-8 and TNF, EM of filters Both systems were hemocompatible but absence of a blood pump did not increase this
 Kopp (2012) Compare Hemos and GasEx with miniaturized V-V ECMO vs. A-V ECMO system Hemos, GasEx and pump characteristics Both systems facilitated LPV but A-V ECMO limited oxygenation and CO2 exchange and increased cardiac work
 Araos (2019) Compare nonprotective (10mL/kg), protective (6mL/kg) or near-apneic MV with V-V ECMO Hemos, GasEx, lung mechanics, LIS, W/D, myofibroblast protein markers ECMO supported near-apneic MV and reduced lung injury on histology and myofibroblast marker expression
 Dubo (2020) Investigate if low spontaneous breathing efforts worsens lung injury vs. controlled near-apneic ventilation during V-V ECMO Hemos, GasEx, lung mechanics, vasopressors, fluid balance, lactate, LIS, W/D, lung cytokines Low intensity spontaneous breathing with high RRs and low TVs did not worsen lung injury versus near-apneic controlled ventilation
 Millar (2020) Investigate safety and efficacy of mesenchymal stromal cell (MSC) administration with V-V ECMO Hemos, GasEx, lung mechanics, LIS, W/D, BAL protein, ECMO characteristics MSC diminished oxygenator function and did not improve oxygenation but reduced lung injury and inflammation on histology
 Qaqish (2020) Establish lung injury with V-V ECMO model with and without surfactant Hemos, GasEx, lung mechanics, LIS, W/D, plasma and BAL inflammatory cytokines, BAL bile acid A lung injury with V-V ECMO model developed and surfactant was tolerated but did not alter function
 Araos (2021) Compare PEEP 0, 10 and 20 levels during near-apneic ventilation with V-V ECMO Hemos, GasEx, lung mechanics, LIS, W/D V-V ECMO with PEEP = 10 limited lung injury, benefited GasEx, and did not worsen Hemos
Studies with a single group and serial measures
 Booke (1995) Investigate if percutaneous V-V ECMO can provide lung support Hemo, GasEx V-V ECMO maintained gas exchange even in paralyzed animals after ALI
 Brederlau (2006) Investigate A-V ECLA’s contribution to gas exchange with different gas flows Hemo, GasEx A-V ECLA removed CO2 but oxygenation was reduced during severe hypoxia by increased shunt fraction
 Zick (2006)

Test oxygenation with a pumpless

interventional lung assist device (ILA)

GasEx, oxygenator blood flow ILA significantly increased oxygenation but the effect was small
 Muellenbach (2009) Investigate TV reductions with A-V ECMO and an open lung approach Hemos, GasEx, lung mechanics A-V ECMO and an open lung approach provided CO2 removal with TVs of 0-2mL/kg and maintained oxygenation increases
 Langer (2014) Investigate V-V ECMO during spontaneous ventilation with 6 different gas flows, before and then after lung injury GasEx, lung mechanics, lung CT scans, plasma IL-1b, TNF, IL-8, IL-10 V-V ECMO can control spontaneous ventilation in healthy sheep and ones with ARDS
 Andresen (2018) Investigate meropenem PKs and a rapid response PK biosensor during V-V ECMO supported Meropenem PK measures Biosensor provided reliable meropenem PK data which ECMO did not alter
 Mendes (2022) Investigate V-V ECMO effects on lung perfusion and Hemos during one-sided lung ventilation and lung collapse and lavage Hemo, GasEx, lactate, Hb ECMO decreased PAP and may have increased shunt, but did not alter lung perfusion distribution with varying V/Q mismatches

ACT, activated thromboplastin time; ALI, acute lung injury; AT2, alveolar type 2 cells; AV, arterio-venous; BAL, bronchoalveolar lavage; BUN, blood urea nitrogen; CBC, complete blood count; CO2, carbon dioxide; CT, computerized tomography; ECLA, extracorporeal lung assist; ECMO, extracorporeal membrane oxygenations; EM, electron micrography; FiO2, fractional inspired oxygen concentration; GasEx, gas exchange; GP, group; H2O, water; Hb, hemoglobin; Hemos, hemodynamics; IL, interleukin; LFTs, liver function tests; LIS, lung injury score on histology; LPV, lung protective ventilation; MV, mechanical ventilation; NO, inhaled nitric oxide; O2, oxygen; PaO2, arterial oxygen pressure; PAP, pulmonary artery pressure; Paw, airways pressure; PEEP, positive end expiratory pressure; PK, pharmacokinetics; PLT -platelet; PTT, partial thromboplastin time; PT, prothrombin time; PVR, pulmonary vascular resistance; Rx, treatment; TAT, thrombin–antithrombin complexes; TNF, tumor necrosis factor; TV, tidal volume; V-A, veno-arterial; V/Q, ventilation/perfusion; V-V, veno-venous; W/D, wet to dry lung ratio;

*Listed measures may not include all those reported in a study

†Summarized from reports’ findings or conclusions

ALI is employed whether a study designated the model as an ALI or acute respiratory distress syndrome one

§depending on the study hemodynamics included systemic and/or pulmonary vascular measures, gas exchange included measures of oxygenation and/or carbon dioxide removal and lung mechanics included static lung compliance and/or airway pressures